Regulation of death receptor-mediated apoptosis pathways

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 11-12, 2000, Pages 1123-1136

  Schmitz, Ingo ^a   Kirchhoff, Sabine ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Caspases; CD95; Death receptors; FLIP

Indexed keywords

CASPASE; CHAPERONE; CYSTEINE PROTEINASE; NERVE GROWTH FACTOR; PHOSPHOTRANSFERASE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR;

APOPTOSIS; CELL TYPE; ENZYME ACTIVATION; NONHUMAN; PROTEIN ANALYSIS; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; HUMANS; LIGANDS; MOLECULAR CHAPERONES; PHOSPHOTRANSFERASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0034536743     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00048-0     Document Type: Review

References (137)

1. CD95(APO-1/Fas)-mediated apoptosis: Live and let die
2. Cell death in development
3. Apoptosis signaling by death receptors
4. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing
5. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
6. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
7. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
8. Death receptors: Signaling and modulation
9. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
10. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
11. Human ICE/CED-3 Protease Nomenclature
12. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
13. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor
14. Caspase structure, proteolytic substrates, and function during apoptotic cell death
15. The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
16. Caspase knockouts: Matters of life and death
17. Alternative splicïng and programmed cell death
18. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
19. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis
20. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
21. BCL-2 family members and the mitochondria in apoptosis
22. Bcl-2 proteins: Regulators of apoptosis or of mitochondrial homeostasis?
23. L, an inhibitor of programmed cell death
24. L-Bak peptide complex: Recognition between regulators of apoptosis
25. L. Implications for the function of the Bcl-2 protein family
26. Solution structure of BID, an intracellular amplifier of apoptotic signaling
27. Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists
28. Channel formation by antiapoptotic protein Bcl-2
29. Bcl-2 family proteins as ion-channels
30. Caspase-14 is a novel developmentally regulated protease
31. Caspase-9, Bcl-xL, and Apaf-1 form a ternary complex
32. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1
33. Two CD95 (APO-1/Fas) signaling pathways
34. A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain
35. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
36. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
37. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
38. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
39. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
40. Caspase activation: The induced-proximity model
41. Mitochondrial control of apoptosis
42. The role of c-FLIP in modulation of CD95-induced apoptosis
43. Differences between CD95 type I and type II cells detected with the CD95 ligand
44. Differential requirement for caspase 9 in apoptotic pathways in vivo
45. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
46. Apaf1 (CED-4 Homolog) regulates programmed cell death in mammalian development
47. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
48. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
49. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
50. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the fas pathway of apoptosis
51. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
52. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/fas death
53. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
54. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
55. Autoactivation of procaspase-9 by Apaf-1 mediated oligomerization
56. An APAF-1.Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
57. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death
58. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus
59. IAP family proteins-suppressors of apoptosis
60. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
61. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
62. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
63. Anti-apoptotic strategies of lymphotropic viruses
64. Inhibition of fas death signals by FLIPs
65. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
66. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
67. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma
68. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
69. Immune escape of tumors in vivo by expression of cellular FLICE- inhibitory protein
70. The Hsp70 and Hsp60 chaperone machines
71. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains
72. Apoptosis: Silencing the death receptors
73. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators
74. GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1
75. BAG-1 modulates the chaperone activity of Hsp70/Hsc70
76. Mammalian protein RAP46: An interaction partner and modulator of 70 kDa heat shock proteins
77. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity
78. A protein that interacts with members of the nuclear hormone receptor family: Identification and cDNA cloning
79. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf- 1
80. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
81. Role of the human heat shock protein hsp70 in protection against stress- induced apoptosis
82. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases
83. Selective protection by hsp 70 against cytotoxic drug-, but not Fas- induced T-cell apoptosis
84. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death
85. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs
86. HSP27 inhibits cytochrome c-dependent activation of procaspase-9
87. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells
88. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis
89. Cellular survival: A play in three Akts
90. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
91. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
92. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B
93. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
94. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
95. Impaired Fas response and autoimmunity in Pten +/- mice
96. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery
97. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
98. Regulation of cell death protease caspase-9 by phosphorylation
99. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
100. Direct control of the Forkhead transcription factor AFX by protein kinase B
101. NF-kappaB activation by tumour necrosis factor requires the Akt serine- threonine kinase
102. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
103. 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB
104. Selective Up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: A mechanism for Th2 resistance from fas-mediated apoptosis
105. Signaling through protein kinase C
106. Protein kinase C regulates Fas (CD95/APO-1) expression
107. Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
108. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax
109. Apoptosis through CD95 (Fas/APO-1), but not a CD40/CD95 chimeric receptor, is inhibited by phorbol-12-myristate-13-acetate
110. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide- mediated apoptosis in Jurkat T lymphocytes
111. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells
112. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases
113. Selective inhibition of protein kinase C isozymes by Fas ligation
114. p90(RSK) blocks bad-mediated cell death via a protein kinase C- dependent pathway
115. Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in jurkat T cells
116. Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis
117. Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis
118. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells
119. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis
120. Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector
121. The MAPK signaling cascade
122. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
123. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
124. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression
125. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling
126. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis
127. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation
128. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
129. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis
130. APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45
131. Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis
132. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex
133. FAP-1: A protein tyrosine phosphatase that associates with Fas
134. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis
135. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells
136. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex
137. Autoimmune lymphoproliferative syndrome, a disorder of apoptosis